About this trial
The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic markers and prognostic biomarkers.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 20-75 years;
Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time;
Women attending a health check-up;
Obtain informed consent and sign an informed consent form.
Disqualifiers
Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment;
Patients with cancer other than cervical cancer or endometrial cancer;
Women who have received hysterectomy or pelvic radiation therapy previously.
Trial population
The investigators establish a population cohort of 6200 women including patients with cervical cancer or endometrial cancer, and women attending to a health check-up.
Trial design
Cohort
Prospective
Treatments tested in this trial
No intervention
Other interventionThis is a prospective observational study with no intervention.
Treatment groups
Trial outcomes
Primary outcomes
progression free survival (PFS)
progression free survival for patients with cervical cancer or endometrial cancer
Sponsors and contacts
Click on the lead sponsor to view all of their trials.